Hormone-sensitive Prostate Cancer
📧 Sign up to get email alerts when something new happens for Hormone-sensitive Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-08Clinical Trial Update: Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations [Phase 2]
A Phase 2 trial evaluating the combination of niraparib, abiraterone acetate, and prednisone for metastatic hormone-sensitive prostate cance…
-
CLINICAL_TRIALS withdrawal · 2018-07-17Clinical Trial Update: Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) [Phase 1, Phase 2]
Clinical trial update on toxicity and pharmacokinetics of 2- and 3-weekly docetaxel in Metastatic Hormone-Sensitive Prostate Cancer. The stu…